ArticleBreast cancer research and treatment2024

Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study.

Joanne L Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.